Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Exercise and Cognition Trials (EXACT)

15 août 2017 mis à jour par: Johns Hopkins University

Human Performance: Role of Acute Exercise in Enhancing Cognitive Function

The purpose of this study is to determine whether an acute bout of exercise may temporarily enhance cognitive function (such as memory or attention span) by measuring behavioral performance on cognitive tests, as well as expression of hormones in circulation associated with brain plasticity and stress.

Aperçu de l'étude

Statut

Complété

Intervention / Traitement

Description détaillée

This is a randomized experiment consisting of three visits for each participant. Participants are determined to be eligible beforehand during a phone screening, in which the various study inclusions and exclusions are determined and the Physical Activity Readiness Questionnaire for Everyone 2015 (PARQ) is administered.

In the first visit, various anthropometric data are collected from participants, such as height, weight, and waist and hip circumference. The participants' blood pressure is also checked for hypertension. The participants are given Dual Energy X-Ray Absorptiometry (DEXA) scans to determine total body composition (bone, fat, and fat-free mass) If the participant is female, a urine analysis to determine pregnancy is required during the visit before the DEXA to ensure safety. Participants are given the Rapid Assessment of Physical Activity (RAPA) questionnaire to assess habitual activity levels. The participants' muscle strength is also measured using the Biodex System 3, an isokinetic dynamometer. The participants then undergo a maximal stress test on a treadmill integrated with a Cardinal Health Metabolic/ECG cart using a modified Balke protocol, beginning at 3 mph, 0% grade, and increasing 2.5% grade every 3 minutes. The ECG component of the metabolic cart will be used for continuous heart rate monitoring as part of the fitness assessment. Cardiorespiratory parameters (VO2, ventilation, respiratory rate) will also be measured throughout the test. Blood pressure is measured during the last 30 seconds of each exercise stage and the rating of perceived exertion (RPE) using the Borg 6 to 20 scale is obtained during each stage. Subjects are urged to give a maximal effort and are pushed until volitional fatigue.

In the second visit, participants are first given a series of cognitive tests designed to quantify such cognitive faculties as visual short-term memory, selective attention, processing speed, and verbal fluency. These tests consist of seeing simple images on a computer screen, such as a series of colored shapes, and responding using a keypad. A blood sample is also collected from the participants to serve as a baseline. The subject is then randomized to one of three groups: the first group rests for 30 minutes; the second group walks on the treadmill at a mild intensity, defined as maintaining 60% of the heart rate observed during the max VO2 from the first visit; the last group walks on the treadmill at a hard intensity, defined as maintaining 80% of the heart rate observed during the max VO2 from the first visit. The subjects then undergo a second blood draw after cooling down, followed immediately by another round of the same cognitive tests. An hour after finishing the exercise intervention, the same procedure of blood draw followed by cognitive tests is repeated, and an hour after that it is repeated again.

The third visit must be about 24 hours after the previous visit. Participants have blood drawn and one final round of cognitive tests.

Type d'étude

Interventionnel

Inscription (Réel)

60

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Maryland
      • Baltimore, Maryland, États-Unis, 21224
        • Johns Hopkins Bayview Medical Center

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 40 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Body mass index (BMI) of between 18.5 and 35 kg/m2
  • Normal or corrected-to-normal vision
  • No contraindications to participation in moderate to hard intensity physical activity

Exclusion Criteria:

  • Self-report of alcohol or substance abuse in the past year or current treatment
  • Women who are pregnant or nursing
  • BMI of < 18.5 or > 35 kg/m2
  • Diabetes mellitus. Subjects will be excluded for diabetes even if controlled by medications
  • Cigarette smoking in the previous 12 weeks
  • Elevated blood pressure (BP) defined as systolic BP ≥ 140 mm Hg or diastolic BP ≥ 90 mm Hg
  • Self-report of cardiovascular disease, cancer, renal disease, and other serious conditions that could be exacerbated by moderate intensity physical activity.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Science basique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Aucune intervention: Rest
Participants randomly assigned to this arm rest quietly for thirty minutes instead of participating in the exercise challenge.
Expérimental: Mild Exercise
Participants randomly assigned to this arm are made to maintain a heart rate equivalent to 60% of the heart rate observed when VO2 max was achieved in the maximal stress test from the first visit.
Participants randomized to an exercise condition will perform treadmill exercise for 30 minutes. Participants will self-select a comfortable walking speed. The treadmill grade will be adjusted to elicit and maintain the target heart rate.
Expérimental: Hard Exercise
Participants randomly assigned to this arm are made to maintain a heart rate equivalent to 80% of the heart rate observed when VO2 max was achieved in the maximal stress test from the first visit.
Participants randomized to an exercise condition will perform treadmill exercise for 30 minutes. Participants will self-select a comfortable walking speed. The treadmill grade will be adjusted to elicit and maintain the target heart rate.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
visual short-term memory questionnaire
Délai: baseline
participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%)
baseline
visual short-term memory questionnaire
Délai: up to 5 minutes post intervention
participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%)
up to 5 minutes post intervention
visual short-term memory questionnaire
Délai: 1 hour after intervention
participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%)
1 hour after intervention
visual short-term memory questionnaire
Délai: 2 hours after intervention
participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%)
2 hours after intervention
visual short-term memory questionnaire
Délai: 24 hours after baseline
participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%)
24 hours after baseline
visual long-term memory questionnaire
Délai: 24 hours after baseline
participants encode images in a cover task at baseline, scored on accuracy (0-100%)
24 hours after baseline
verbal fluency
Délai: baseline
participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words
baseline
verbal fluency
Délai: up to 5 minutes post intervention
participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words
up to 5 minutes post intervention
verbal fluency
Délai: 1 hour after intervention
participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words
1 hour after intervention
verbal fluency
Délai: 2 hours after intervention
participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words
2 hours after intervention
verbal fluency
Délai: 24 hours after baseline
participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words
24 hours after baseline
cortisol in circulation
Délai: baseline
in nanograms per milliliter (ng/ml)
baseline
cortisol in circulation
Délai: up to 5 minutes post intervention
in nanograms per milliliter (ng/ml)
up to 5 minutes post intervention
cortisol in circulation
Délai: 1 hour after intervention
in nanograms per milliliter (ng/ml)
1 hour after intervention
cortisol in circulation
Délai: 2 hours after intervention
in nanograms per milliliter (ng/ml)
2 hours after intervention
cortisol in circulation
Délai: 24 hours after baseline
in nanograms per milliliter (ng/ml)
24 hours after baseline
igf-1 in circulation
Délai: baseline
insulin-like growth factor 1 in nanograms per milliliter (ng/ml)
baseline
igf-1 in circulation
Délai: up to 5 minutes post intervention
insulin-like growth factor 1 in nanograms per milliliter (ng/ml)
up to 5 minutes post intervention
igf-1 in circulation
Délai: 1 hour after intervention
insulin-like growth factor 1 in nanograms per milliliter (ng/ml)
1 hour after intervention
igf-1 in circulation
Délai: 2 hours after intervention
insulin-like growth factor 1 in nanograms per milliliter (ng/ml)
2 hours after intervention
igf-1 in circulation
Délai: 24 hours after baseline
insulin-like growth factor 1 in nanograms per milliliter (ng/ml)
24 hours after baseline
bdnf in circulation
Délai: baseline
brain-derived neurotrophic factor in nanograms per milliliter (ng/ml)
baseline
bdnf in circulation
Délai: up to 5 minutes post intervention
brain-derived neurotrophic factor in nanograms per milliliter (ng/ml)
up to 5 minutes post intervention
bdnf in circulation
Délai: 1 hour after intervention
brain derived neurotrophic factor in nanograms per milliliter (ng/ml)
1 hour after intervention
bdnf in circulation
Délai: 2 hours after intervention
brain-derived neurotrophic factor in nanograms per milliliter (ng/ml)
2 hours after intervention
bdnf in circulation
Délai: 24 hours after baseline
brain-derived neurotrophic factor in nanograms per milliliter (ng/ml)
24 hours after baseline
general executive functioning as assessed by the stroop test questionnaire
Délai: baseline
participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds
baseline
general executive functioning as assessed by the stroop test questionnaire
Délai: up to 5 minutes post intervention
participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds
up to 5 minutes post intervention
general executive functioning as assessed by the stroop test questionnaire
Délai: 1 hour after intervention
participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds
1 hour after intervention
general executive functioning as assessed by the stroop test questionnaire
Délai: 2 hours after intervention
participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds
2 hours after intervention
general executive functioning as assessed by the stroop test questionnaire
Délai: 24 hours after baseline
participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds
24 hours after baseline
general executive functioning as assessed by the flanker task questionnaire
Délai: baseline
participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
baseline
general executive functioning as assessed by the flanker task questionnaire
Délai: up to 5 minutes post intervention
participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
up to 5 minutes post intervention
general executive functioning as assessed by the flanker task questionnaire
Délai: 1 hour after intervention
participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
1 hour after intervention
general executive functioning as assessed by the flanker task questionnaire
Délai: 2 hours after intervention
participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
2 hours after intervention
general executive functioning as assessed by the flanker task questionnaire
Délai: 24 hours after baseline
participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
24 hours after baseline
general executive functioning as assessed by the irrelevant capture task questionnaire
Délai: baseline
participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
baseline
general executive functioning as assessed by the irrelevant capture task questionnaire
Délai: up to 5 minutes post intervention
participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
up to 5 minutes post intervention
general executive functioning as assessed by the irrelevant capture task questionnaire
Délai: 1 hour after intervention
participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
1 hour after intervention
general executive functioning as assessed by the irrelevant capture task questionnaire
Délai: 2 hours after intervention
participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
2 hours after intervention
general executive functioning as assessed by the irrelevant capture task questionnaire
Délai: 24 hours after baseline
participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds
24 hours after baseline

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
total and regional bone mass
Délai: baseline
as assessed by dual-energy x-ray absorptiometry (DEXA) scan, in grams per square centimeter (g/cm2)
baseline
total and regional fat and fat-free mass
Délai: baseline
as assessed by dual-energy x-ray absorptiometry (DEXA) scan in grams per square centimeter (g/cm2)
baseline
habitual activity levels
Délai: baseline
as assessed by Rapid Assessment of Physical Activity questionnaire, possible scores are: Active, Under Active Regular, Under Active Regular- Light Activities, Under Active, Sedentary
baseline
muscle strength
Délai: baseline
as measured by isokinetic testing using the Biodex System 3
baseline
cardiorespiratory endurance
Délai: baseline
as assessed by maximal stress test, represented by heart rate at maximal oxygen uptake
baseline
body mass index (BMI)
Délai: baseline
measured in kilograms per square meter (kg/m2)
baseline
waist-to-hip ratio
Délai: baseline
baseline

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Peter Searson, PhD, Johns Hopkins University
  • Chercheur principal: Kerry Stewart, EdD, Johns Hopkins University
  • Chercheur principal: Howard Egeth, PhD, Johns Hopkins University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 août 2016

Achèvement primaire (Réel)

2 mai 2017

Achèvement de l'étude (Réel)

2 mai 2017

Dates d'inscription aux études

Première soumission

31 octobre 2016

Première soumission répondant aux critères de contrôle qualité

4 novembre 2016

Première publication (Estimation)

8 novembre 2016

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 août 2017

Dernière mise à jour soumise répondant aux critères de contrôle qualité

15 août 2017

Dernière vérification

1 août 2017

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner